Cited by 12Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major DepressionPsychotherapy Techniques and Applications

Quality of life after response to acute-phase cognitive therapy for recurrent depression

Open access
Vittengl, Jeffrey R., Jha, Manish K., Minhajuddin, Abu, Thase, Michael E., Jarrett, Robin B.·2021·Journal of Affective Disorders

Abstract

Background Adults with major depressive disorder (MDD) often experience reduced quality of life (QOL). Efficacious acute-phase treatments, including cognitive therapy (CT) or medication, decrease depressive symptoms and, to a lesser degree, increase QOL. We tested longer-term changes in QOL after response to acute-phase CT, including the potential effects of continuation treatment for depression and time-lagged relations between QOL and depressive symptoms.Methods Responders to acute-phase CT (N = 290) completed QOL and depressive symptom assessments repeatedly for 32 post-acute months. Higher-risk responders were randomized to 8 months of continuation treatment (CT, fluoxetine, or pill placebo) and then entered a 24-month follow-up. Lower-risk responders were only assessed for 32 months.Results On average, large gains in QOL made during acute-phase CT response were maintained for 32 months. Continuation CT or fluoxetine did not improve QOL relative to pill placebo. Controlling for residual depressive symptoms, higher QOL after acute-phase CT response was a protective factor against MDD relapse and recurrence. Higher QOL predicted subsequent reductions in depressive symptom severity, but depressive symptom severity did not predict subsequent changes in QOL.Limitations Generalization of results to other patient populations, treatments, and measures is uncertain. The clinical trial was not designed to test relations between QOL and depression. Replication is needed before clinical application of these results.Conclusions Gains in QOL made during response to acute-phase CT are relatively stable and may help protect against relapse/recurrence. Continuation CT or fluoxetine may not further improve QOL among acute-phase CT responders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jad.2020.09.059

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • QOL improvement has been evidenced to predict lower odds of depression relapse and recurrence.

    “Further, QOL improvement has been evidenced to predict lower odds of depression relapse and recurrence and thus, is a very important outcome for interventions [83].”

    From Personalized machine learning guided intervention for optimizing lifestyle behaviors in depression: a pilot study (2026) · cites this paper as [83]

    The Results section reports that higher quality of life after response to acute-phase cognitive therapy predicted less relapse or recurrence. But the analysis used quality-of-life level at that point, not improvement in quality of life, as the predictor; it therefore does not establish the claim about improvement specifically. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Beck AT, Rush AJ, Shaw BF, & Emery G (1979). Cognitive Therapy of Depression. New York: Guilford Press.
  2. First MB, Spitzer RL, Gibbon M, & Williams JB (1996). Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0). New York, NY: New York State Psychiatric Institute, Biometrics Research Department.

Cited by

Sorted by citations

Authors
Vittengl, J. R., Jha, M. K., Minhajuddin, A., Thase, M. E., & Jarrett, R. B.
Affiliations
  • Truman State University (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • The University of Texas Southwestern Medical Center (US)
  • University of Pennsylvania (US)
Corresponding author
  • Vittengl, Jeffrey R.
  • Jarrett, Robin B.
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2021-01
Volume
278
Pages
218-225
ISSN
0165-0327 (ISSN-L)
OpenAlex
W3087570700
Cited by
12
References
47
Citations by year
2026: 3 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 2
FWCI
1.45
Type
journal article
Language
en
Open access
Locations
  • Journal of Affective Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Mental Health
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
Keywords
quality of life, major depressive disorder, recurrent depression, cognitive therapy, continuation treatment, fluoxetine, relapse prevention, depression recurrence, residual depressive symptoms, long-term outcomes
MeSH terms
Adult, Depression, Depressive Disorder, Major, Major Depressive Disorder, Fluoxetine, Follow-Up Studies, Humans, Quality of Life, Recurrence, Cognitive Behavioral Therapy, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review